7ACRES, a subsidiary of Supreme Cannabis Inc (OTCMKTS:SPRWF), has received the approval of Health Canada for five additional flowering rooms. Supreme Cannabis made the announcement today outlining that the Ontario facility has been expanded by 50,000 sqft. The additional space will be important towards boosting the production capacity.

Details about the expansion

An official working at 7ACRES says that the expansion of flowering room space is from 180,000 sqft to 230,000 sqft. He adds that the estimated annual production will scale up from approximately 26,250kg to 33,580kg.

Supreme Cannabis hopes to witness further production efficiencies and it attributes that to the licensing of all 25 flowering rooms. The company projects that 7ACRES might be able to produce about 50,000kg.

The President and Founder of Supreme Cannabis John Fowler opines, “With five more flowering rooms at 7ACRES now approved by Health Canada, the finish line is in sight”.

The official adds that 7ACRES is currently working towards attaining full production capacity. If all moves according to plan, it might be able to fulfill the demand of the company’s top-notch cannabis.

Major developments in the course of this year

Supreme Cannabis has in the course of this year made other tremendous steps in business. The company unveiled Cambium Plant Sciences in Goderich, Ontario. Cambium is one of its wholly-owned subsidiaries and it will focus on revolutionizing the agricultural cannabis genetics. Asides from that, it will all work to redefine the cultivation economics and consumer experiences across the global cannabis industry.

Cambium focuses on the systematic application of technology, research, and science in its undertakings. It seeks to develop the next generation of premium cannabis genetics for medical, recreational and wellness applications. The subsidiary’s innovative mission is to serve the fast growing global cannabis market with the agriculturally-focused, disease resistant, premium seed stock.

The General Manager of Cambium Dr. Alan Darlington is optimistic that Cambium will make an important addition to the cannabis industry. He says that will be possible because they intend to revolutionize strain development. This move will enable them to enhance the wider industry’s outputs.

Supreme Cannabis says it has already set aside $14 million for the set up of a cannabis-focused facility. It will focus on cannabis research and innovation.